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The increasing incidence of allogeneic trans-
plants in Coccidioides-endemic areas such as the
southwestern United States and Latin America high-
lights the importance of considering reactivation of
donor coccidioidomycosis in transplant recipients.
We report the case of a 42-year-old Nicaraguan
woman who had multiple firm, violaceous subcu-
taneous nodules 1 month after her orthotopic liver
transplant. Histopathology of a biopsy specimen,
immunodiffusion assay, and donor serologic testing
results were consistent with disseminated cutaneous
coccidioidomycosis secondary to donor reactiva-
tion. Screening of donors in Coccidioides-endemic
areas with serology, organ culture, and chest radi-
ography should be considered before transplanta-
tion. Recipients in endemic areas may benefit from
prophylactic antifungal therapy.
CASE REPORT
A 42-year-old Nicaraguan woman presented
3 months after orthotopic liver transplant secondary
to autoimmune hepatitis with 2 months of head-
ache, fever, and multiple firm, violaceous, subcu-
taneous nodules on the back, right buttock, and
extremities (Fig 1). Lesions were tender andwarm to
palpation but lacked erythema, pallor, or fluctu-
ance. Lymphadenopathy was not appreciated on
physical examination. Her medications included
tacrolimus.
Chest computed tomography found multiple pul-
monary nodules; wedge biopsy of lung found a
fibrocaseocalcific granuloma with Grocott’s methe-
namine silver stain showing 4-mbudding oval yeast,
suggestive of Coccidioides endospores. Liver biopsy
findings were consistent with peliosis hepatitis.
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nodule found scattered round, thick-walled spores
with granular cytoplasm, massive pseudoepitheliom-
atous hyperplasia, and granulomatous dermal inflam-
mation on histopathology (Fig 2). Direct microscopy
found spherules containing endospores dispersed in
the dermis with surrounding infiltrate rich in chronic
inflammatory cells, neutrophils, and granulomatous
inflammation, consistent with coccidioidomycosis
(Fig 3). Culture on Sabouraud’s dextrose agar showed
suedelike, greyish growth.
Histologic findings were corroborated by IgM1-
modified immunodiffusion. The donor tested positive
for IgG Coccidioides antibody despite remaining
symptom free, indicating latent infection and intro-
ducing the possibility that this patient was afflicted by
reactivated donor-derived Coccidioides. The patient’s
lesions resolved completelywith 500mgvoriconazole
twice daily for 3 months, after initially not responding
to 4 months of 800 mg of daily fluconazole.
DISCUSSION
Differential diagnoses include erythema nodo-
sum, lipomas, cutaneous lymphoma, pseudolym-
phoma, and disseminated coccidioidomycosis.
Additional infectious causes should be considered
in a transplant patient with eruptive subcutaneous
nodules, such as histoplasmosis, cryptococcosis,
paracoccidioidomycosis, and leishmaniasis.
The diagnosis of donor coccidioidomycosis in this
case highlights the importance of considering reac-
tivation in posttransplant care, as there is an emerging
incidence of allogeneic transplants in Coccidioides-
endemic areas such as the southwestern United States
and Latin America. There are few reported cases of
donor-derived coccidioidomycosis outside of the
dermatology literature.1-6 Fewer than 5% of donors2352-5126
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Fig 2. Cutaneous coccidioidomycosis. Massive pseudoe-
pitheliomatous hyperplasia and granulomatous dermal
inflammation. Careful searching at high power is often
needed to find the spherules, which are 100 m in
diameter. (Hematoxylin-eosin stain.)
Fig 3. Cutaneous coccidioidomycosis: Spherule contain-
ing endospores, with surrounding infiltrate rich in chronic
inflammatory cells, neutrophils, and granulomatous
inflammation. (Hematoxylin-eosin stain.)
Fig 1. Cutaneous coccidioidomycosis. One of multiple
firm, violaceous subcutaneous nodules.
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infection, and 70% of those with active infection
have a reactivation of the disease instead of a primary
infection.7 Infection risk is amplified by posttrans-
plant immunosuppressant therapy, and risk is great-
est within the first posttransplant year, as 70% ofdisseminated coccidioidomycosis cases occur during
this time.8 Donors in endemic areas should be
screened with serology, organ cultures, and chest
radiography. Cases of Coccidioides transmission,
despite such precautionary measures, have been
reported9; prophylactic antifungal therapy is, there-
fore, recommended for patients undergoing trans-
plant in Coccidioides-endemic areas.
Choices for initial treatment include fluconazole,
itraconazole, voriconazole, and posaconazole.10 Our
patient was treated with voriconazole after not
responding to a fluconazole trial.
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